Ignite Creation Date:
2024-05-06 @ 3:24 AM
Last Modification Date:
2024-10-26 @ 11:33 AM
Study NCT ID:
NCT02281318
Status:
COMPLETED
Last Update Posted:
2018-08-06
First Post:
2014-10-30
Brief Title:
Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline